Latest News - Alcon

Wednesday, October 11, 2017 | Medical Studies, Alcon

New Data Shows Astigmatism Tends to Worsen Following Cataract Surgery With a Standard Monofocal IOL

Alcon presented a real-world data analysis that looks at the impact of not treating astigmatism during cataract surgery, and results from the "More to See" survey that reveal a widespread la…

Read the full story

Tuesday, October 10, 2017 | Conferences, Medical Studies, Alcon

Data Presentations at ESCRS on Astigmatism, CyPass, and AcrySof IOLs

Alcon will present a real-world data analysis that looks at the impact of not treating astigmatism during cataract surgery, and results from the “More to See” survey that reveal a widespre…

Read the full story

Friday, October 06, 2017 | Product Releases, Alcon

Alcon Receives CE Mark for AutonoMe Preloaded IOL Delivery System with Clareon IOL

Alcon has achieved European CE Mark for the Clareon IOL with the AutonoMe delivery system. AutonoMe is the first automated, disposable, preloaded IOL delivery system that enables precise delivery of t…

Read the full story

Monday, October 02, 2017 | Conferences, Product Releases, Alcon

Alcon to Introduce Clareon IOL, Conduct Several Presentations, at Annual ESCRS Meeting

Alcon will introduce its new monofocal IOL, Clareon, at the European Society of Cataract & Refractive Surgeons (ESCRS) congress taking place October 7-11 in Lisbon, Portugal. In addition, Alcon wi…

Read the full story

Monday, September 25, 2017 | Partnerships, Alcon

Alcon Teams Up With US Olympians Laurie Hernandez and Tobin Heath to Launch the Dailies Invisible Edge Campaign

Alcon is launching a new consumer education campaign called "Invisible Edge" with the help of Olympic gold- and silver-medalist Laurie Hernandez and two-time gold-medalist Tobin Heath. These…

Read the full story

Monday, September 18, 2017 | Acquisitions/Mergers, Alcon, ThromboGenics

ThromboGenics Regains Global Rights to Jetrea

ThromboGenics announced that it will regain full global rights to Jetrea (ocriplasmin) from Alcon based on a mutual agreement. Under the terms of the agreement, ThromboGenics will receive a cash amoun…

Read the full story

Monday, September 04, 2017 | Management/Leadership, Alcon, Novartis

Novartis CEO Joseph Jimenez to Retire Next Year; Vasant Narasimhan Named as Replacement

Novartis announced Monday that CEO Joseph Jimenez will step down from his role effective January 31, 2018, to be replaced by Vasant Narasimhan, the company's current global head of drug developmen…

Read the full story

Thursday, August 31, 2017 | Glaucoma, Alcon

Alcon Announces CyPass Micro-Stent’s Unique Procedure Code Becomes Effective, Paving the Way for Medicare Reimbursement

Alcon announced that the unique Current Procedural Terminology (CPT) code 0474T issued by the American Medical Association for the newly launched CyPass Micro-Stent is now effective. The CyPass Micro-…

Read the full story

Tuesday, July 18, 2017 | Earnings & Financials, Alcon

Latest Novartis Earnings Show Signs of a Rebound at Alcon

As part of its second quarter earnings, Novartis reported that sales at its Alcon unit accelerated in the second quarter. Novartis Chief Executive Joe Jimenez said the results increase the number of o…

Read the full story

Wednesday, June 07, 2017 | Medical Studies, Alcon

New Alcon Survey Reveals People are Happier, More Satisfied With Their Lives After Cataract Surgery

A new survey from Alcon demonstrates that people experience significant emotional and lifestyle benefits after cataract surgery. Nearly three in four respondents who expressed an opinion agreed that a…

Read the full story

Thursday, June 01, 2017 | Product Releases, Alcon

Alcon's ORA System with VerifEye Technology Now Available in Canada

Alcon Canada, a division of Alcon, announced that the Valley Laser Eye Centre, in Abbotsford, BC, recently became the first facility in Canada to offer the ORA System with VerifEye technology to patie…

Read the full story

Wednesday, May 31, 2017 | Product Releases, Alcon

Alcon Announces Launch of New DAILIES AquaComfort Plus Patient-Friendly Packaging

Alcon launched new US-specific packaging for DAILIES AquaComfort Plus (DACP) spherical contact lenses in 90-, 30- and 5-packs to assist patients with proper lens wear and care. The new packaging is th…

Read the full story

Wednesday, May 31, 2017 | Partnerships, Alcon

CheckedUp Broadens Its Reach in Ophthalmology

CheckedUp announced the expansion of its existing partnership with Alcon to educate patients about cataract surgical treatment options through the CheckedUp platform. The CheckedUp platform engages pa…

Read the full story

Tuesday, May 16, 2017 | Product Releases, Alcon

Alcon Introduces SYSTANE ICAPS Chewable Eye Vitamin, the First Chewable AREDS2 Formula in the United States

Alcon announced the introduction of SYSTANE ICAPS Chewable AREDS2 eye vitamin in the US market to support eye health in people with intermediate to advanced age-related macular degeneration (AMD).…

Read the full story

Friday, May 05, 2017 | Management/Leadership, Alcon

Stephen S. Lane, MD, Joins Alcon as Chief Medical Officer and Global Head Franchise Clinical Strategy

Alcon has appointed Stephen S. Lane, MD, as Chief Medical Officer and Global Head Franchise Clinical Strategy. He will join the company on June 1. In his new role, Dr. Lane will lead the integratio…

Read the full story
Load More